Kazakhstan vs Syrian Arab Republic: Drug use disorder deaths by sex
Kazakhstan
92.06 deaths
in 2021
Syrian Arab Republic
78.36 deaths
in 2021
Kazakhstan rank
29th
Syrian Arab Republic rank
32nd
Drug use disorder deaths by sex over time
- Kazakhstan
- Syrian Arab Republic
How they compare
Kazakhstan currently reports 92.06 deaths against 78.36 deaths in Syrian Arab Republic, a difference of 13.7 deaths.
That makes Kazakhstan's figure about 1.2 times Syrian Arab Republic's.
Across all 22 years both countries report, Kazakhstan has been ahead every year.
Kazakhstan ranks 29th and Syrian Arab Republic ranks 32nd of 194 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 107.77 deaths | 51.54 deaths | 56.23 deaths | Kazakhstan |
| 2010s | 93.54 deaths | 70.81 deaths | 22.73 deaths | Kazakhstan |
| 2020s | 93.25 deaths | 76.55 deaths | 16.71 deaths | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher drug use disorder deaths by sex, Kazakhstan or Syrian Arab Republic?
- Kazakhstan, at 92.06 deaths against 78.36 deaths in Syrian Arab Republic as of 2021.
- What is the difference in drug use disorder deaths by sex between Kazakhstan and Syrian Arab Republic?
- 13.7 deaths, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Syrian Arab Republic?
- 22 years are reported by both, from 2000 to 2021.
- How do Kazakhstan and Syrian Arab Republic rank globally for drug use disorder deaths by sex?
- Kazakhstan ranks 29th and Syrian Arab Republic ranks 32nd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Drug use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from drug use disorders in females.